Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Dec;31(10):1342-1354.
doi: 10.1093/heapol/czw071. Epub 2016 Jul 3.

HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa

James R Hargreaves  1 , Anne Stangl  2 , Virginia Bond  3 , Graeme Hoddinott  4 , Shari Krishnaratne  5 , Hlengani Mathema  4 , Maureen Moyo  6 , Lario Viljoen  4 , Laura Brady  2 , Kirsty Sievwright  2 , Lyn Horn  4 , Kalpana Sabapathy  7 , Helen Ayles  5   6 , Nulda Beyers  4 , Peter Bock  4 , Sarah Fidler  8 , Sam Griffith  9 , Janet Seeley  3 , Richard Hayes  7 ; HPTN 071 (PopART) study team
Affiliations
Randomized Controlled Trial

HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa

James R Hargreaves et al. Health Policy Plan. 2016 Dec.

Abstract

Background: Stigma and discrimination related to HIV and key populations at high risk of HIV have the potential to impede the implementation of effective HIV prevention and treatment programmes at scale. Studies measuring the impact of stigma on these programmes are rare. We are conducting an implementation science study of HIV-related stigma in communities and health settings within a large, pragmatic cluster-randomized trial of a universal testing and treatment intervention for HIV prevention in Zambia and South Africa and will assess how stigma affects, and is affected by, implementation of this intervention.

Methods/design: A mixed-method evaluation will be nested within HIV prevention trials network (HPTN) 071/PopART (Clinical Trials registration number NCT01900977), a three-arm trial comparing universal door-to-door delivery of HIV testing and referral to prevention and treatment services, accompanied by either an immediate offer of anti-retroviral treatment to people living with HIV regardless of clinical status, or an offer of treatment in-line with national guidelines, with a standard-of-care control arm. The primary outcome of HPTN 071/PopART is HIV incidence measured among a cohort of 52 500 individuals in 21 study clusters. Our evaluation will include integrated quantitative and qualitative data collection and analysis in all trial sites. We will collect quantitative data on indicators of HIV-related stigma over 3 years from large probability samples of community members, health workers and people living with HIV. We will collect qualitative data, including in-depth interviews and observations from members of these same groups sampled purposively. In analysis, we will: (1) compare HIV-related stigma measures between study arms, (2) link data on stigma to measures of the success of implementation of the PopART intervention and (3) explore changes in the dominant drivers and manifestations of stigma in study communities and the health system.

Discussion: HIV-related stigma may impede the successful implementation of HIV prevention and treatment programmes. Using a novel study-design nested within a large, community randomized trial we will evaluate the extent to which HIV-related stigma affects and is affected by the implementation of a comprehensive combination HIV prevention intervention including a universal test and treatment approach.

Keywords: AIDS; Africa; HIV; implementation science; key populations; stigma; treatment as prevention.

PubMed Disclaimer

References

    1. Bond V. 2014. . Silos, science and stigma: community experiences of HIV treatment and prevention in Zambia and South Africa. Presented at the 23rd Annual Canadian Conference on HIV/AIDS Research May 1-4, 2014, St. John s, Newfoundland, Canada.
    1. Bond V, Hoddinott G, Musheke M. et al. . 2013. . Broad brush surveys of HIV prevention, treatment and care in 21 Zambian and South African communites to prepare for HPTN071 (PopART). Technical Report submitted to theInternational Initiative for Impact Evaluation (September 2013).
    1. Brenner BG, Roger M, Routy JP. et al. . 2007. . High rates of forward transmission events after acute/early HIV-1 infection . The Journal of Infectious Diseases 195 : 951 – 9 . - PubMed
    1. Brown L, Macintyre K, Trujillo L. 2003. . Interventions to reduce HIV/AIDS stigma: what have we learned? AIDS Education and Prevention 15 : 49 – 69 . - PubMed
    1. Bunnell R, Ekwaru JP, Solberg P. et al. . 2006. . Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda . AIDS 20 : 85 . - PubMed

Publication types

Substances